In a 61-year-old woman with depression and anxiety who has been on duloxetine 60 mg in the morning and 30 mg in the afternoon for eight years and now experiences unexplained mood swings, can she be switched to escitalopram (Lexapro)?

Switching from Duloxetine to Escitalopram: Critical Considerations

Before switching this patient from duloxetine to escitalopram (Lexapro), you must first evaluate for possible bipolar disorder, as her unexplained mood swings with "highs and lows" raise significant concern for undiagnosed bipolar disorder rather than unipolar depression—switching to an SSRI without mood stabilization could precipitate manic episodes. 1, 2

Immediate Assessment Required

Rule Out Bipolar Disorder First

• Manic episode symptoms to assess: greatly increased energy, severe trouble sleeping, racing thoughts, reckless behavior, unusually grand ideas, excessive happiness or irritability, talking more or faster than usual 2
• The description of "mood swings where she is high and low with unknown triggers" is concerning for bipolar disorder, where SSRIs like escitalopram can trigger manic episodes 1, 2
• If bipolar disorder is confirmed or suspected, do not switch to escitalopram alone—this requires mood stabilizer therapy first 1

If Bipolar Disorder is Ruled Out: Switching Considerations

Efficacy Comparison

Escitalopram has demonstrated superior efficacy to duloxetine in head-to-head trials for depression and anxiety. 3, 4

• Escitalopram showed superior mean MADRS score improvement versus duloxetine at weeks 1,2,4, and 8 (treatment difference 2.6 points, P<0.01) 3
• Response rates: 67.1% for escitalopram vs 53.2% for duloxetine (P<0.001) 3
• Remission rates: 54.3% for escitalopram vs 44.4% for duloxetine (P<0.05) 3
• Number needed to treat favoring escitalopram: 8 for response, 11 for remission 3

Tolerability and Safety Profile

Escitalopram has superior tolerability compared to duloxetine, particularly important at age 61. 5, 3, 6

• Significantly fewer patients discontinue escitalopram due to adverse events (4.9% vs 19.2%, P=0.007) 7, 3
• Duloxetine commonly causes nausea (most common reason for discontinuation), vomiting, sweating, and has higher discontinuation rates than SSRIs 1, 5
• For patients over 60 years, escitalopram is a preferred agent with better tolerability than other antidepressants 5

Critical Safety Considerations for Age 61

Cardiac monitoring is essential at this age when switching antidepressants. 8

• Citalopram/escitalopram maximum dose is reduced for patients >60 years due to QT prolongation risk 8
• Maximum escitalopram dose for patients >60: 10 mg daily (not the standard 20 mg) 8
• Duloxetine does not cause clinically significant QT prolongation, but escitalopram has the least effect on CYP450 enzymes, reducing drug interaction risk 1

Switching Protocol

Discontinuation Syndrome Prevention

Both duloxetine and escitalopram require slow tapering to prevent discontinuation syndrome. 1, 2

Duloxetine discontinuation syndrome symptoms include: 1

• Dizziness, fatigue, headache, nausea, vomiting, diarrhea
• Insomnia, vertigo, sensory disturbances, paresthesias
• Anxiety, irritability, agitation
• Duloxetine has been specifically associated with discontinuation symptoms 1

Recommended switching approach:

1. Taper duloxetine slowly over 2-4 weeks: reduce from 90 mg total daily dose by 30 mg every 1-2 weeks 1, 9
2. Cross-taper is safest: begin escitalopram 5 mg daily when duloxetine reaches 30-60 mg daily 1
3. Start escitalopram at LOW dose (5 mg) given age >60 and serotonin syndrome risk 1, 8, 1
4. Monitor closely for 24-48 hours after each dose change for serotonin syndrome symptoms 1

Serotonin Syndrome Monitoring

When cross-tapering two serotonergic drugs, monitor for serotonin syndrome symptoms: 1, 2

• Mental status changes: agitation, confusion, anxiety
• Neuromuscular: tremors, muscle rigidity, hyperreflexia
• Autonomic: hypertension, tachycardia, diaphoresis, hyperthermia
• GI symptoms: nausea, vomiting, diarrhea

Target Dosing

For a 61-year-old with anxiety and depression: 5, 2

• Maximum escitalopram dose: 10 mg daily (reduced for age >60) 8
• Standard starting dose after taper: 5 mg daily for 1 week, then increase to 10 mg daily 2
• Take once daily, morning or evening, with or without food 2

Common Pitfalls to Avoid

1. Do not abruptly stop duloxetine—this causes severe discontinuation syndrome with the 8-year duration of use 1
2. Do not exceed 10 mg escitalopram daily at age 61—increased cardiac risk 8
3. Do not switch without ruling out bipolar disorder first—SSRIs can precipitate mania 1, 2
4. Do not combine with other serotonergic drugs without careful monitoring 1, 2

Monitoring Requirements

• Blood pressure and pulse during duloxetine taper (SNRIs affect BP) 1
• Mood and energy levels weekly during switch (watch for hypomania/mania) 1, 2
• Discontinuation symptoms during duloxetine taper 1, 2
• Consider baseline ECG given age >60 and escitalopram's QT effects 8